HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

lapatinib (GW572016)

an EGFR-ErbB-2 inhibitor
Also Known As:
GW572016; GW 282974X; GW 572016; GW-282974X; GW-572016; GW282974X; N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine; Tykerb; lapatinib ditosylate
Networked: 1024 relevant articles (162 outcomes, 354 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Koch, Kevin M: 18 articles (01/2015 - 01/2005)
2. Spector, Neil L: 18 articles (01/2015 - 09/2002)
3. Baselga, José: 15 articles (04/2015 - 04/2007)
4. Arteaga, Carlos L: 14 articles (08/2015 - 06/2009)
5. Xia, Wenle: 14 articles (01/2014 - 09/2002)
6. de Azambuja, Evandro: 13 articles (07/2015 - 03/2008)
7. Crown, John: 13 articles (01/2015 - 12/2006)
8. Oliva, Cristina: 12 articles (06/2013 - 12/2006)
9. Osborne, C Kent: 11 articles (09/2015 - 05/2008)
10. Di Leo, Angelo: 11 articles (05/2015 - 12/2008)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Carcinoma (Carcinomatosis)
5. Stomach Neoplasms (Stomach Cancer)

Related Drugs and Biologics

1. trastuzumab (Herceptin)
2. capecitabine (Xeloda)
3. Epidermal Growth Factor Receptor (EGF Receptor)
4. Protein-Tyrosine Kinases (Tyrosine Kinase)
5. Phosphotransferases (Kinase)
6. Hormones
7. letrozole (Femara)
8. Aromatase (CYP19)
9. Paclitaxel (Taxol)
10. taxane

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Aftercare (After-Treatment)
4. Neoadjuvant Therapy
5. Radiotherapy